Nimodipine Capsules (marketed as Nimotop).

Press Release/Announcement

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; January 1, 2006.

This U.S. Food and Drug Administration alert reminds health care professionals that nimodipine should only be administered orally, and that intravenous or parenteral administration can cause serious adverse events.

Information

Related Resources From the Same Author(s)

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions.

January 25, 2017

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico.

July 26, 2006

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor).

August 12, 2015

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

October 7, 2009

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11.

September 1, 2021

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Relenza (zanamivir) inhalation powder.

October 21, 2009

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

October 21, 2009

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

February 20, 2008

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

November 19, 2008

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Wear face masks with no metal during MRI exams.

December 16, 2020

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff.

October 3, 2022

An Introduction to the Improved FDA Prescription Drug Labeling.

November 1, 2006

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

April 8, 2009

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health.

June 6, 2018

Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry.

January 9, 2013

FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication

November 6, 2019

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

A Review of FDA’s Approach to Medical Product Shortages.

November 16, 2011

Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication.

May 4, 2022

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

Drug Shortages: Root Causes and Potential Solutions.

November 13, 2019

Luer Connector Misconnections: Under-Recognized but Potentially Dangerous Events.

August 15, 2012

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications.

March 4, 2015

Safety Problems With Your Child's Medical Device?

July 31, 2013

Making Medical Devices Safer at Home.

January 9, 2013

Four Medication Safety Tips for Older Adults.

June 18, 2014

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

March 26, 2008

FDA 101: How to Use the Consumer Complaint System and MedWatch.

June 25, 2008

Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry.

December 23, 2020

Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

March 22, 2006

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Reprocessing of Reusable Medical Devices.

January 11, 2012

MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

June 22, 2005

Drug Shortages.

April 27, 2011

My Medicines.

July 9, 2014

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

Teaching Kids About Using Medicine Safely.

February 29, 2012

BeSafeRx: Know Your Online Pharmacy.

October 10, 2012

Lock it Up: Medicine Safety in Your Home.

November 30, 2011

FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved.

January 13, 2016

OpenFDA.

June 11, 2014

Be an Active Member of Your Health Care Team.

May 21, 2014

FDA MedWatch and Patient Safety Tutorial.

December 10, 2008

FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment.

June 7, 2006

Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors.

January 13, 2016

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Postmarket Drug Safety Information for Patients and Providers.

November 19, 2008

Human Factors and Medical Devices.

March 27, 2005

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Questions and Answers on FDA's Adverse Event Reporting System (FAERS).

September 17, 2008

Safety Information on Alaris SE Infusion Pumps.

November 15, 2006

Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.

March 3, 2010

FDA public health notification: unretrieved device fragments.

January 30, 2008

Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States.

June 23, 2020

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

June 2, 2021

Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products.

November 23, 2005

Strategic Plan for Preventing and Mitigating Drug Shortages.

November 13, 2013

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

Safe Use Initiative.

November 18, 2009

6 Tips to Avoid Medication Mistakes.

July 18, 2007

Quick Tips for Buying Medicines Over the Internet.

March 6, 2005

FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam).

June 3, 2015

Shelhigh, Inc. implantable medical devices.

May 2, 2007

Spotlight Archive.

March 6, 2005

FDA Pharmacists Help Consumers Use Medicines Safely.

November 19, 2014

FDA Patient Safety News. A Video News Show for Health Professionals.

March 6, 2005

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Related Resources

Medication guides: patient medication information. A proposed rule by the Food and Drug Administration.

June 28, 2023

WebM&M Cases

The Danger of 10% Intravenous Calcium Chloride Extravasation.

April 26, 2023

Annual Perspective

Annual Perspective: Topics in Medication Safety

March 31, 2022

Medication safety issues with newly authorized PAXLOVID.

January 12, 2022

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing.

February 24, 2022 - February 24, 2022

WebM&M Cases

An Inadvertent Bolus of Norepinephrine.

May 26, 2021

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

Dangerous wrong-route errors with tranexamic acid.

September 30, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

WebM&M Cases

Fatal Patient-Controlled Analgesia (PCA) Opioid-Induced Respiratory Depression

May 27, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

WebM&M Cases

One Bronchoscopy, Two Errors

January 1, 2019

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Safe handling of concentrated electrolyte products from outsourcing facilities during critical drug shortages.

June 13, 2018

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

Safe implementation of standard concentration infusions in paediatric intensive care.

August 24, 2016

Recommendations and low-technology safety solutions following neuromuscular blocking agent incidents.

February 3, 2016

August 12, 2015

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Medication safety in the operating room: a survey of preparation methods and drug concentration consistencies in children's hospitals in the United States.

September 24, 2014

Interventions to reduce medication errors in pediatric intensive care.

August 20, 2014

Potential inaccuracy of electronically transmitted medication history information used for medication reconciliation.

February 26, 2014

Effect of barcode-assisted medication administration on emergency department medication errors.

October 2, 2013

Perspective

Quality and Safety Challenges in Critical Care: Preventing and Treating Delirium in the Intensive Care Unit

December 1, 2012

WebM&M Cases

Patient Safety and Adherence to Self-Administered Medications

July 1, 2011

Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.

January 19, 2011

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

See More About The Topic

Nimodipine Capsules (marketed as Nimotop).

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Nimodipine Capsules (marketed as Nimotop).

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

PSNet Log in

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site